Daewoong Pharmaceutical said it has voluntarily withdrawn its application for Chinese marketing approval of Nabota, its ...

Asan Medical Center (AMC) announced Thursday that Professor Jeon Jae-yong of the Department of Rehabilitation Medicine has ...

Roche Korea has expanded the reimbursement criteria for Enspryng (satralizumab), its treatment for neuromyelitis optica ...

Dx&Vx said it has signed its first-ever global out-licensing and co-development agreement with a U.S.-based biotech company ...

Seers Technology announced on Thursday that its malignant arrhythmia multi-stage prediction AI software, which can be used in ...

The government has finalized the composition of the “Medical Workforce Supply and Demand Estimation Committee” to discuss the ...

A Korean research team has successfully chemically synthesized herpotrichone, a rare natural substance evaluated for its ...

G2G Bio, a Korean drug delivery platform company specializing in long-acting injectables, is accelerating its push for global ...

Korea's EverEx has raised 14.8 billion won ($10.7 million) in a Series B round to accelerate its global expansion and advance ...

Clopidogrel is a representative drug that prevents blood clots and the recurrence of stroke. It must be converted into an ...

Bladder cancer has a high cure rate, with a five-year survival rate of 95 percent when detected early. However, bladder cancer is difficult to manage and deadly, with a recurrence rate of up to 70 per ...

A research team at Seoul National University Hospital (SNUH) has identified a novel blood-based biomarker capable of enabling ...